Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, A McPherson… - The Journal of …, 2012 - Wiley Online Library
Next‐generation sequencing is making sequence‐based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, A McPherson… - The Journal of …, 2012 - infona.pl
Next‐generation sequencing is making sequence‐based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
[引用][C] Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, BJ McConeghy… - Journal of …, 2012 - elibrary.ru
[引用][C] Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C WU, AW WYATT, FAN MO, E LI… - … of pathology (Print), 2012 - pascal-francis.inist.fr
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and
aggressive prostate cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …
aggressive prostate cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk… - Journal of …, 2012 - research.manchester.ac.uk
Next-generation sequencing is making sequence-based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk… - The Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Next-generation sequencing is making sequence-based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
[PDF][PDF] Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
J Pathol, 2012 - academia.edu
Next-generation sequencing is making sequence-based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
C Wu, AW Wyatt, AV Lapuk, A McPherson… - Journal of …, 2012 - search.ebscohost.com
Next-generation sequencing is making sequence-based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
[HTML][HTML] Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, A McPherson… - The Journal of …, 2012 - ncbi.nlm.nih.gov
Next-generation sequencing is making sequence-based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, A McPherson… - Journal of …, 2012 - profiles.wustl.edu
Next-generation sequencing is making sequence-based molecular pathology and
personalized oncology viable. We selected an individual initially diagnosed with …
personalized oncology viable. We selected an individual initially diagnosed with …